Correlation Between Alx Oncology and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alx Oncology and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alx Oncology and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alx Oncology Holdings and Fate Therapeutics, you can compare the effects of market volatilities on Alx Oncology and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alx Oncology with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alx Oncology and Fate Therapeutics.
Diversification Opportunities for Alx Oncology and Fate Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Alx and Fate is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Alx Oncology Holdings and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Alx Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alx Oncology Holdings are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Alx Oncology i.e., Alx Oncology and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Alx Oncology and Fate Therapeutics
Given the investment horizon of 90 days Alx Oncology Holdings is expected to generate 0.95 times more return on investment than Fate Therapeutics. However, Alx Oncology Holdings is 1.05 times less risky than Fate Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 181.00 in Alx Oncology Holdings on September 25, 2024 and sell it today you would lose (19.00) from holding Alx Oncology Holdings or give up 10.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Alx Oncology Holdings vs. Fate Therapeutics
Performance |
Timeline |
Alx Oncology Holdings |
Fate Therapeutics |
Alx Oncology and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alx Oncology and Fate Therapeutics
The main advantage of trading using opposite Alx Oncology and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alx Oncology position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |